Goodrx Holdings Inc
$ 3.68
-1.08%
07 Aug - close price
- Market Cap 1,255,415,000 USD
- Current Price $ 3.68
- High / Low $ 3.85 / 3.63
- Stock P/E 61.33
- Book Value 1.84
- EPS 0.06
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.03 %
- 52 Week High 5.81
- 52 Week Low 1.77
About
GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.
Analyst Target Price
$3.51
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-05 | 2026-05-06 | 2026-02-25 | 2025-11-04 | 2025-08-06 | 2025-05-07 | 2025-02-27 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-29 | 2023-11-09 |
| Reported EPS | 0.04 | 0.07 | 0.09 | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 |
| Estimated EPS | 0.04 | 0.07 | 0.0917 | 0.09 | 0.1 | 0.0957 | 0.1 | 0.09 | 0.09 | 0.08 | 0.07 | 0.06 |
| Surprise | 0 | 0 | -0.0017 | -0.01 | -0.01 | -0.0057 | -0.01 | -0.01 | -0.01 | 0 | 0.01 | 0 |
| Surprise Percentage | 0% | 0% | -1.8539% | -11.1111% | -10% | -5.9561% | -10% | -11.1111% | -11.1111% | 0% | 14.2857% | 0% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: GDRX
2026-08-08 03:10:44
GoodRx (GDRX) stock rose 13.8% following its Q2 2026 earnings report, driven by stronger margins and an adjusted EBITDA of US$63.7m, despite a slight revenue decline. The company is seeing increased traction in subscription services and Pharma Direct revenue, validating its margin-focused strategy. However, the bear case highlights a 12% drop in monthly active consumers and ongoing concerns about the relevance of its prescription coupon model, as management transitions the business to new revenue streams.
2026-08-06 16:10:48
This article provides an earnings forecast for GoodRx Holdings Inc (GDRX), highlighting its current earnings forecast score, average price target, and analyst ratings. Based on 15 analysts, the stock has a "Hold" rating, with an average price target of $5.00. The expected revenue for the next quarter is $199.39 million.
2026-08-01 08:39:23
Wells Fargo analysts have provided insights on Teladoc (TDOC) and GE Healthcare Technologies Inc (GEHC). Stan Berenshteyn maintained a Hold rating on Teladoc with a $6.00 price target, while Larry Biegelsen reiterated a Buy rating on GE Healthcare Technologies Inc with an $85.00 price target. The article also notes the general analyst consensus for both companies.
2026-07-24 22:10:11
GoodRx Holdings Inc (GDRX) currently has an earnings forecast score of 6.67, placing it 338th out of 485 in the Software & IT Services industry. The average analyst price target for GDRX is $5.00, with forecasts ranging from $3.00 to $7.00. Based on ratings from 15 analysts, the general sentiment for GoodRx Holdings Inc stock is to 'Hold'.
2026-07-24 08:42:40
This article provides a comprehensive overview of GoodRx Holdings Inc (GDRX), including its stock performance, key financial figures, and analyst ratings. It highlights that GoodRx's fundamentals are stable with high growth potential, and its valuation is considered fairly valued within the Software & IT Services industry. The company is noted for its platform facilitating medication savings and telehealth services, with institutional ownership being very high.
2026-07-16 20:41:43
GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, engaged in equity compensation activity, exercising restricted stock units (RSUs) to acquire 5,792 shares of Class A Common Stock. Concurrently, 2,947 shares were withheld for tax purposes at a price of $3.01 per share. Following these transactions, Chan directly holds 11,527 shares of Class A Common Stock and 57,925 restricted stock units.
